{
  "docId": "019de511-345d-7570-a494-480f2370811c",
  "docSlug": "ec9eb0ed92f9fb3cafb36e44028c44da",
  "documentTitle": "MaxCyte | IPO Presentation Deck | 34 slides",
  "authorId": "maxcyte",
  "authorName": "MaxCyte",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2021-07-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7843866,
  "pageNumber": 28,
  "pageCount": 34,
  "prevPage": 27,
  "nextPage": 29,
  "slideType": "market_sizing",
  "function": "size_opportunity",
  "density": "dense",
  "nDataPoints": 6,
  "notes": "The chart uses a stacked bar format to show the composition of programs across Preclinical, Clinical, and Commercial stages.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de511-345d-7570-a494-480f2370811c/28",
  "deckHref": "/decks/019de511-345d-7570-a494-480f2370811c",
  "deckJsonHref": "/decks/019de511-345d-7570-a494-480f2370811c.json",
  "deckAnchorHref": "/decks/019de511-345d-7570-a494-480f2370811c#slide-28",
  "components": [
    {
      "bbox": {
        "h": 0.65,
        "w": 0.65,
        "x": 0.05,
        "y": 0.18
      },
      "kind": "chart",
      "text": "Projected Number of Genetically-modified Cell Therapy Programs (2020-26)",
      "attrs": null,
      "subkind": "bar-stacked",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "05e5bd89-31c8-42e1-a962-db9df01a67ee",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.2,
        "x": 0.75,
        "y": 0.2
      },
      "kind": "metric",
      "text": "13% CAGR 2020-2026",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3266a59d-08c4-4092-a59a-6b35ed048acb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.2,
        "x": 0.75,
        "y": 0.7
      },
      "kind": "metric",
      "text": ">10 Distinct approved indications by 2026",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "69f86f75-bbda-42b3-8409-fb828d495921",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.2,
        "x": 0.75,
        "y": 0.45
      },
      "kind": "metric",
      "text": ">50 Approved therapies by 2026",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f9a2f480-a73c-452e-86a3-7e76472254f6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.65,
        "x": 0.05,
        "y": 0.85
      },
      "kind": "paragraph",
      "text": "Consistent, substantial market growth, including in the non-viral delivery segment, is expected to increase MaxCyte's addressable opportunity overall",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b5d29368-e0cf-4e06-81db-223d1be09dfa",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.3,
        "x": 0.03,
        "y": 0.94
      },
      "kind": "source-note",
      "text": "Source: DeciBio Cell Therapy Model, Interview Feedback",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9c49c58d-bdfe-4610-95a4-8077a43b1a38",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.8,
        "x": 0.03,
        "y": 0.03
      },
      "kind": "title",
      "text": "Cell Therapy Market is Expected to Double Over Next 5 Years across All Approaches and Segments",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4c2ef3af-0b4d-4375-910c-905df6b85745",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 29,
      "from": 28,
      "beatId": "e53fc857-ec80-4649-8149-04da1aefc20d",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Why Now",
      "beatSlug": "sequoia-pitch-why-now",
      "evidence": "Slides 28-29 discuss market growth and opportunity.",
      "position": 4,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}